Showing results (11-20 of 17) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Social Science & Medicine (1982)|February 24, 2015
A tale of two cities: stigma and health outcomes among people with HIV who inject drugs in St. Petersburg, Russia and Kohtla-Järve, EstoniaSara E Burke, Sarah K Calabrese, John F Dovidio, et al.The Journal of Infectious Diseases|January 26, 2010
CCL3L1 copy number is a strong genetic determinant of HIV seropositivity in Caucasian intravenous drug usersKristi Huik, Maarja Sadam, Tõnis Karki, et al.European Addiction Research|February 3, 2022
Take-Home Naloxone Kits: Attitudes and Likelihood-Of-Use Outcomes from a European Survey of Potential Overdose WitnessesRebecca McDonald, Sibella Breidahl, Katri Abel-Ollo, et al.Plos One|June 16, 2016
A CCL5 Haplotype Is Associated with Low Seropositivity Rate of HCV Infection in People Who Inject DrugsKristi Huik, Radko Avi, Merit Pauskar, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|February 11, 2014
Association between HIV-1 tropism and CCR5 human haplotype E in a Caucasian populationKristi Huik, Radko Avi, Helen Uibopuu, et al.Plos One|August 13, 2013
CCR5 haplotypes influence HCV serostatus in Caucasian intravenous drug usersKristi Huik, Radko Avi, Andrew Carrillo, et al.The International Journal on Drug Policy|July 19, 2022
A rapid assessment of take-home naloxone provision during COVID-19 in EuropeRebecca McDonald, Desiree Eide, Katri Abel-Ollo, et al.Pageof 2